Abstract
Stem cell-based therapy stands as a robust experimental treatment for ischemic stroke. Stem cells derived from fetal, embryonic, and adult tissues serve as potential sources for transplantable cells in the setting of ischemic stroke. However, the search continues for finding an optimal cell line for clinical use. Muse cells, a distinct subset of mesenchymal stem cells found sporadically in the connective tissue of nearly every organ, may be a suitable candidate due to its safety and accessibility. These cells have been investigated for therapeutic usage in chronic kidney disease, liver disease, acute myocardial infarction, and stroke. Muse cells display the ability to engraft and differentiate into the host neural network unlike many other cell lines which only display bystander immunomodulating effects. Taking advantage of this unique engraftment and differentiation mechanism behind Muse cells’ therapeutic effects on the central nervous system, as well as other organ systems, will undoubtedly advance the cells’ utility for cell-based regenerative medicine in stroke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abe T, Aburakawa D, Niizuma K et al (2020) Intravenously transplanted human multilineage-differentiating stress-enduring cells afford brain repair in a mouse lacunar stroke model. Stroke 51(2):601–611
Alessio N, Squillaro T, Özcan S et al (2018) Stress and stem cells: adult muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells. Oncotarget 9(27):19328–19341
Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L, Toren A, Constantini S, Rechavi G (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6(2)
Benjamin EJ et al (2019) Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation 139(10):e56–e528
Bernard L, Parham L (2009) Ethical issues in stem cell research. Endocr Rev 30(3):10
Chen ZZ et al (2008) Beneficial effect of autologous transplantation of bone marrow stromal cells and endothelial progenitor cells on cerebral ischemia in rabbits. Neurosci Lett 445(1)
Chen S et al (2016) Differentiation of isolated human umbilical cord mesenchymal stem cells into neural stem cells. Int J Ophthalmol 9(1):41–47
Dabrowska S et al (2019) Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation 16(1):178
Dezawa M (2018) Clinical trials of muse cells. Muse Cells 1103:3
Dezawa M, Niizuma K, Tominaga T (2019) Actualization of neural regenerative medicine by intravenous drip of donor-derived muse cells. Brain Nerve 71(8):895–900
Doeppner TR et al (2015) Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med 4(10):1131–1143
Eterno V et al (2014) Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-met signaling. Oncotarget 5(3):613–633
Felfly H et al (2010) Hematopoietic stem cell transplantation protects mice from lethal stroke. Exp Neurol 225(2)
Friedenstein AJ, Piatetzky S II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16(3):381–390
Gorin NC (2019) Bone marrow harvesting for HSCT. In: The EBMT handbook. Springer
Grabowski M, Brundin P, Johansson BB (1992a) Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: ingrowth of afferent fibers from the host brain. Exp Neurol 116(2):105–121
Grabowski M et al (1992b) Vascularization of fetal neocortical grafts implanted in brain infarcts in spontaneously hypertensive rats. Neuroscience 51(3):673–682
Gutiérrez-Fernández M et al (2013) Adipose tissue-derived stem cells in stroke treatment: from bench to bedside. Discov Med 16(86):37–43
Hao L et al (2014) Stem cell-based therapies for ischemic stroke. Biomed Res Int 2014:468748
Higgins JM (2015) Red blood cell population dynamics. Clin Lab Med 35(1):43–57
Hsiao HH et al (2014) Acute cerebral infarct with elevated factor VIII level during the thrombocytopenic stage after hematopoietic stem cell transplant. Exp Clin Transplant 12(2):171–172
Hu MS, Longaker MT (2017) A MUSE for skin regeneration. J Invest Dermatol 137(12):2471–2472
Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17(7):796–808
Ikegame Y et al (2011) Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13(6):675–685
Ishizaka S et al (2013) Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 44(3):720–726
JapicCTI-183834, J.I (2020) Exploratory study of CL2020 in patients with ST-elevation acute myocardial infarction
JapicCTI-184103, J.I (2018) A randomized, double-blind, placebo-controlled clinical study of CL2020 in ischemic stroke patient
JapicCTI-184563, J.I (2018) A clinical study of CL2020 in patients with epidermolysis bullosa
JapicCTI-194841, J.I (2019) A clinical study of CL2020 in patients with spinal cord injury
JapicCTI-195067, J.I (2019) A confirmatory study of CL2020 in patients with ST-elevation myocardial infarction
Jin Soo Lee JMH, Moon GJ, Lee PH, Ahn YH, Bang OY, STARTING Collaborators (2010) A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28(6):8
jRCT2043190112, J.I (2020) The clinical trial of CL2020 for neonatal hypoxic ischemic encephalopathy
Kasahara Y et al (2016) Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model. Transl Res 176:69–80
Kempermann G, Song H, Gage FH (2015) Neurogenesis in the adult hippocampus. Cold Spring Harb Perspect Biol 7(9):a018812
Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM, McGrogan M, Reitman MA, Bynum L (2000) Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55(4):5
Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, Decesare S, Jovin T, Zafonte R, Lebowitz J, Flickinger JC, Tong D, Marks MP, Jamieson C, Luu D, Bell-Stephens T, Teraoka J (2005) Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103(1):8
Krause M et al (2019) Cell-based therapies for stroke: are we there yet? Front Neurol 10:656
Kuroda S et al (2018) Muse cell: a new paradigm for cell therapy and regenerative homeostasis in ischemic stroke. Adv Exp Med Biol 1103:187–198
Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97
Lee JE, Lee DR (2011) Human embryonic stem cells: derivation, maintenance and cryopreservation. Int J Stem Cells 4(1):9–17
Leng Z, Sun D, Huang Z et al (2019) Quantitative analysis of SSEA3+ cells from human umbilical cord after magnetic sorting. Cell Transplant 28(7):907–923. 52
Leong WK et al (2012) Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl Med 1(3):177–187
Li N, Hua J (2017) Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci 74(13):2345–2360
Liang Y et al (2013) The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability. Chin J Cancer 32(4):205–212
Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441(7097):1094–1096
Liu S-J et al (2014) Co-grafting of neural stem cells with olfactory en sheathing cells promotes neuronal restoration in traumatic brain injury with an anti-inflammatory mechanism. J Neuroinflammation 11
Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4(5):399–415
Ma S et al (2014) Immunobiology of mesenchymal stem cells. Cell Death Differ 21(2):216–225
Mampalam TJ et al (1988) Neuronal changes in fetal cortex transplanted to ischemic adult rat cortex. J Neurosurg 69(6):904–912
McElreavey KD et al (1991) Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton's jelly portion of human umbilical cord. Biochem Soc Trans 19(1):29S
Minatoguchi S et al (2018) Acute myocardial infarction, cardioprotection, and muse cells. Adv Exp Med Biol 1103:153–166
Mohamed-Ahmed S, Fristad I, Lie SA, Suliman S, Mustafa K, Vindenes H et al (2018) Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. Stem Cell Res Ther 9(1)
Mushahary D et al (2018) Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A 93(1):19–31
Nathan C, Ding A (2010) Nonresolving inflammation. Cell 140(6):871–882
Nishina T, Hoshikawa KT, Ueno Y (2018) Current cell-based therapies in the chronic liver diseases. Adv Exp Med Biol 1103:243–253
Ogura F et al (2014) Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev 23(7):717–728
Okano H, Temple S (2009) Cell types to order: temporal specification of CNS stem cells. Curr Opin Neurobiol 19(2):112–119
Ovbiagele B et al (2013) Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke 44(8):2361–2375
Sacco RL et al (2013) An updated definition of stroke for the 21st century. Stroke 44(7):2064–2089
Santilli G et al (2010) Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS One 5(1):e8575
Savitz SI et al (2005) Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovas Dis 20(2):7
Shinozuka K et al (2013) Stem cell transplantation for neuroprotection in stroke. Brain Sci 3(1):239–261
Shohei Wakao HA, Kushida Y, Dezawa M (2014) Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues. Pathol Int 64(1):9
Song CG et al (2018) Stem cells: a promising candidate to treat neurological disorders. Neural Regen Res 13(7):1294–1304
Stonesifer C et al (2017) Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. Prog Neurobiol 158:94–131
Tanaka T, Nishigaki K, Minatoguchi S et al (2018) Mobilized Muse cells after acute myocardial infarction predict cardiac function and remodeling in the chronic phase. Circ J 82(2):561–571
Uchida H et al (2016) Transplantation of unique subpopulation of fibroblasts, Muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells 34(1):160–173
Uchida H et al (2017) Human muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke 48(2):428–435
Uchida N, Kumagai N, Kondo Y (2018) Application of muse cell therapy for kidney diseases. Adv Exp Med Biol 1103:199–218
Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells – current trends and future prospective. Biosci Rep 35(2)
Valeria Battistella GRdF, da Fonseca LMB, Mercante D, Gutfilen B, Goldenberg RCS, Dias JV, Kasai-Brunswick TH, Wajnberg E, Rosado-de-Castro PH, Alves-Leon SV, Mendez-Otero R, Andre C (2011) Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 6(1):8
Wakao S et al (2011) Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci U S A 108(24):9875–9880
Wakao S et al (2014) Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues. Pathol Int 64(1):1–9
Wakao S, Kushida Y, Dezawa M (2018) Basic characteristics of Muse cells. Adv Exp Med Biol 1103:13–41
Yamada Y et al (2018) S1P-S1PR2 Axis mediates homing of muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction. Circ Res 122(8):1069–1083
Young W (2018) Future of Muse cells. Muse Cells 1103:7
Zents K, Copray S (2016) The therapeutic potential of induced pluripotent stem cells after stroke: evidence from rodent models. Curr Stem Cell Res Ther 11(2):166–174
Zhang RL et al (2014) Stroke increases neural stem cells and angiogenesis in the neurogenic niche of the adult mouse. PLoS One 9(12):e113972
Zhao X, Moore D (2018) Neural stem cells: developmental mechanisms and disease modeling. Cell Tissue Res 371(1):1–6
Zhao T et al (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212–215
Zuk PA et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13(12):4279–4295
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Park, Y.J. et al. (2020). A Museum of Stem Cells Points to Muse Cells as Robust Transplantable Cells for Stroke: Review. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 11. Advances in Experimental Medicine and Biology(), vol 1312. Springer, Cham. https://doi.org/10.1007/5584_2020_596
Download citation
DOI: https://doi.org/10.1007/5584_2020_596
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71924-1
Online ISBN: 978-3-030-71925-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)